Hyperhidrosis Treatment Market Research Report - Forecast till 2027

Hyperhidrosis Treatment Market Size, Growth and Trends Analysis By Type (Primary Hyperhidrosis, Secondary Generalized Hyperhidrosis), By Treatment (Botulinum Toxin Injections, Topical Treatment, Surgical Treatment, Oral Medication, Microwave Therapy, Others) and By End-User (Dermatology Clinics, Ambulatory Surgery Centers, Payers/Patients, Others)-Forecast to 2027

ID: MRFR/Pharma/7003-HCR | February 2021 | Region: Global | 140 Pages         

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Hyperhidrosis Treatment Market, by Type

1.1.2. Global Hyperhidrosis Treatment Market, by Treatment

1.1.3. Global Hyperhidrosis Treatment Market, by End User

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.5. Breakdown of Primary Respondents

3.6. Forecasting Techniques

3.7. Research Methodology for Market Size Estimation

3.8. Bottom-Up Approach

3.9. Top-Down Approach

3.10. Data Triangulation

3.11. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

5.3. Pipeline Product Analysis

6. GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY TYPE

6.1. Overview

6.2. Primary Hyperhidrosis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Secondary Generalized Hyperhidrosis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7. GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT

7.1. Overview

7.2. Botulinum Toxin Injections

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. Topical Treatment

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4. Surgical Treatment

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5. Oral Medication

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6. Microwave Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.7. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8. GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY END USER

8.1. Overview

8.2. Dermatology Clinics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3. Ambulatory Surgery Centers

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4. Payers/Patients

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9. GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. UK

9.3.1.4. Italy

9.3.1.5. Spain

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitor Dashboard

10.3. Major Growth Strategy in the Global Hyperhidrosis Treatment Market

10.4. Competitive Benchmarking

10.5. The Leading Player in terms of Number of Developments in the Global Hyperhidrosis Treatment Market

10.6. Key Developments & Growth Strategies

10.7. Major Players Financial Matrix & Market Ratio

11. COMPANY PROFILE

11.1. Allergan PLC

11.1.1. Company Overview

11.1.2. Products/Services Offered

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Brickell Biotech Inc.

11.3. Cynosure

11.4. Dermadry Laboratories lnc.

11.5. Dermira Inc.

11.6. GlaxoSmithKline PLC

11.7. Miramar Labs, Inc.

11.8. Sesderma

11.9. Ulthera Inc.

11.10. Others

12. APPENDIX

12.1. References

12.2. Related Reports

 

LIST OF TABLES

TABLE 1 GLOBAL HYPERHIDROSIS TREATMENT MARKET SYNOPSIS, 2020–2027

TABLE 2 GLOBAL HYPERHIDROSIS TREATMENT MARKET ESTIMATES & FORECAST, 2020–2027 (USD MILLION)

TABLE 3 GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 4 GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)

TABLE 5 GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 6 GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 7 NORTH AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 10 US: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 11 US: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)

TABLE 12 US: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 13 CANADA: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 14 CANADA: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)

TABLE 15 CANADA: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 16 LATIN AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 17 LATIN AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)

TABLE 18 LATIN AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 19 EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 20 EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)

TABLE 21 EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

 

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL HYPERHIDROSIS TREATMENT MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL HYPERHIDROSIS TREATMENT MARKET

FIGURE 4 GLOBAL HYPERHIDROSIS TREATMENT MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL HYPERHIDROSIS TREATMENT MARKET SHARE, BY TREATMENT, 2020 (%)

FIGURE 6 GLOBAL HYPERHIDROSIS TREATMENT MARKET SHARE, BY END USER, 2020 (%)

FIGURE 7 GLOBAL HYPERHIDROSIS TREATMENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 AMERICAS: HYPERHIDROSIS TREATMENT MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: HYPERHIDROSIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: HYPERHIDROSIS TREATMENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: HYPERHIDROSIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: HYPERHIDROSIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL HYPERHIDROSIS TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 ALLERGAN PLC: KEY FINANCIALS

FIGURE 16 ALLERGAN PLC: SEGMENTAL REVENUE

FIGURE 17 ALLERGAN PLC: REGIONAL REVENUE

FIGURE 18 BRICKELL BIOTECH INC.: KEY FINANCIALS

FIGURE 19 BRICKELL BIOTECH INC.: SEGMENTAL REVENUE

FIGURE 20 BRICKELL BIOTECH INC.: REGIONAL REVENUE

FIGURE 21 CYNOSURE: KEY FINANCIALS

FIGURE 22 CYNOSURE: SEGMENTAL REVENUE

FIGURE 23 CYNOSURE: REGIONAL REVENUE

FIGURE 24 DERMIRA INC.: KEY FINANCIALS

FIGURE 25 DERMIRA INC.: SEGMENTAL REVENUE

FIGURE 26 DERMIRA INC.: REGIONAL REVENUE

FIGURE 27 GLAXOSMITHKLINE PLC: KEY FINANCIALS

FIGURE 28 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE

FIGURE 29 GLAXOSMITHKLINE PLC: REGIONAL REVENUE

FIGURE 30 MIRAMAR LABS, INC.: KEY FINANCIALS

FIGURE 31 MIRAMAR LABS, INC.: SEGMENTAL REVENUE

FIGURE 32 MIRAMAR LABS, INC.: REGIONAL REVENUE

Hyperhidrosis Treatment Market

Hyperhidrosis Treatment Market is expected to hold a value of USD 1,925.9 Million By 2027 at a CAGR of 6.07%

Segmentation

By Type Primary Hyperhidrosis Secondary Generalized Hyperhidrosis
By Treatment Botulinum Toxin Injections Topical Treatment Surgical Treatment Oral Medication Microwave Therapy
By End-User Dermatology Clinics Ambulatory Surgery Centers Payers/Patients

Key Players

  • Brickell Biotech Inc. (US)
  • Allergan PLC (Ireland)
  • Cynosure (US)
  • Dermira Inc. (US)
  • Dermadry Laboratories inc. (Canada)
  • GlaxoSmithKline PLC (UK)
  • Sesderma (Spain)
  • Miramar Labs Inc. (US)
  • Ulthera Inc. (US)

Drivers

  • Increasing research studies being conducted for the treatment of hyperhidrosis
  • Extensive use of botulinum toxin injections
  • Development in laser and electronic therapy for hyperhidrosis treatment
  • Rising support by the public and private companies
Speak to Analyst Request a Free Sample

Hyperhidrosis Treatment Market Synopsis


Hyperhidrosis Treatment Market is expected to hold a value of USD 1,925.9 Million by 2025 at a CAGR of 6.07%. Despite being one of the most commonly occurring conditions, the hyperhidrosis treatment market continues to grow at a moderate rate. Antiperspirants and topical products are the first line of treatment in the hyperhidrosis treatment market. However, there is no permanent cure to hyperhidrosis yet. However, there has been high activity in terms of technological developments and product developments in the past few years. Also, with growing awareness about the treatment options and patient’s inclination towards novel approaches has been an encouraging factor for the companies to invest in this market.


Hyperhidrosis Treatment Market Influencer


The increasing usage of botulinum toxin for the treatment of hyperhidrosis has been instrumental in boosting the market growth. The rising number of products by key players in the market are likely to act as a promising factor for the growth of the hyperhidrosis treatment market.


Market Drivers



  • Increasing research studies being conducted for the treatment of hyperhidrosis

  • Extensive use of botulinum toxin injections

  • Development in laser and electronic therapy for hyperhidrosis treatment

  • Rising support by the public and private companies

  • Increasing efforts to increase awareness about hyperhidrosis. For instance, in November 2018, the International Hyperhidrosis Society ran an awareness campaign, “Hyperhidrosis Awareness Month.” Through this campaign, they reached more than 170,000 healthcare professionals, and about 101,000 visitors looked up their campaign website from 206 different countries.

  • Increasing prevalence of hyperhidrosis. In the US, the prevalence of hyperhidrosis has grown from 2.8% in 2004 to 4.8% in 2018. Nearly 58% of these people reported having primary hyperhidrosis. In Germany, the prevalence of hyperhidrosis is almost 16.3%. The prevalence of primary and secondary hyperhidrosis is 13.9% in Japan.


Market Restraints



  • Lack of approved products in the hyperhidrosis treatment market and unavailability of a permanent cure

  • The high cost of treatment


Hyperhidrosis Treatment Market Segmentation


By Type



  • Primary Hyperhidrosis: It is a disorder with symptoms such as abnormal sweating. The sweating is not necessarily related to exercise or heat. The most commonly affected areas by hyperhidrosis are armpits, palms of the hands, soles of the feet, under the breasts, and groin area. The primary hyperhidrosis segment captures the larger hyperhidrosis treatment market share.



  • Secondary Generalized Hyperhidrosis: In secondary generalized hyperhidrosis the sweating is caused due to another medical condition such as hypertension and cardiovascular diseases, among others. It does not affect any particular body part, and the and perspiration occurs all over the affected person’s body.


By Treatment



  • Botulinum Toxin Injections: Botulinum toxin (Botox) is a neurotoxin, which is a relatively new treatment approach for the treatment of hyperhidrosis. Botox is the Food and Drug Administration (FDA)-approved treatment for axillary hyperhidrosis. Generally, doctors recommend Botox injections only when the patient continues to experience the hyperhidrosis episodes despite the use of prescription antiperspirants, and the condition does not improve.



  • Topical Treatment: Topical treatment generally includes over-the-counter (OTC) antiperspirants. These are considered the first line of treatment for hyperhidrosis. If the patient is not relieved by using the OTC antiperspirants, prescription antiperspirants are used.



  • Surgical Treatment: The surgical treatment includes sweat gland removal surgery and endoscopic thoracic sympathectomy (ETS). Sweat gland removal surgery is done when there is a need for permanent sweat gland removal in case of severe armpit sweating. ETS is a minimally invasive surgical procedure commonly used for the hyperhidrosis of hands. Besides that, lasers treatments are also a common surgical procedure.



  • Oral Medication: Although there are no specific drugs targeted for the treatment of hyperhidrosis, oral medicines such as anticholinergics have found some success and are commonly used. Some of the examples of anticholinergics are glycopyrrolate, oxybutynin, benztropine, propantheline, and others.



  • Microwave Therapy: Also known as microwave thermolysis, works on the principle of directing energy to the sweat glands of the armpit and destroying them.



  • Others: The other segment includes iontophoresis.


By End-User



  • Dermatology Clinics: Dermatology clinics account for the largest hyperhidrosis treatment market share of this segment in the hyperhidrosis treatment market. Dermatology clinics offer a number of treatments ranging from Botox treatment to surgical and laser therapy.



  • Ambulatory Surgery Centers: Ambulatory surgical centers offer outpatient services related to hyperhidrosis treatment. Ambulatory surgery centers are the fastest-growing segment in the hyperhidrosis market.



  • Payers/Patients: This segment includes the individual patients who tend to buy the medication, topical creams, and antiperspirants for the treatment of hyperhidrosis.



  • Others: This segment includes research organizations and academic institutions.


By Region



  • Americas: The largest regional hyperhidrosis treatment market. Countries such as the US and Canada have been at the forefront of the healthcare industry over the years. High awareness about hyperhidrosis, adoption of novel therapeutic approaches, and high per capita disposable incomes are contributing factors for the growth of the market in this region.



  • Europe: Europe is the second-largest hyperhidrosis treatment market for hyperhidrosis treatment. The increasing number of players involved in the development of the new therapeutic approaches, rising government support for the research & development, and rising awareness about the disorder are some of the factors driving the growth in the region.



  • Asia-Pacific: The Asia-Pacific region is anticipated to be the fastest-growing region in the hyperhidrosis treatment market. This region has been witnessing a surge in the number of people afflicted with the disorder. Additionally, growing awareness of this disorder has been an important factor in the growth of the hyperhidrosis market.



  • Middle East & Africa: The smallest market due to limited healthcare infrastructure, lack of awareness about the disease condition, and low per capita disposable incomes in underdeveloped regions of the Middle East and Africa.


Hyperhidrosis Treatment Market Key Players



  • Allergan PLC (Ireland)

  • Brickell Biotech Inc. (US)

  • Cynosure (US)

  • Dermadry Laboratories lnc. (Canada)

  • Dermira Inc. (US)

  • GlaxoSmithKline PLC (UK)

  • Miramar Labs, Inc. (US)

  • Sesderma (Spain)

  • Ulthera Inc. (US)



Report Scope:
Report Attribute/Metric Details
  Market Size   2025: USD 1,925.9 Million
  CAGR   2025: 6.07%.
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Treatment, End user, Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Brickell Biotech Inc. (US), Allergan PLC (Ireland), Cynosure (US), Dermira Inc. (US), Dermadry Laboratories inc. (Canada), GlaxoSmithKline PLC (UK), Sesderma (Spain), Miramar Labs, Inc. (US), and Ulthera Inc. (US)
  Key Market Opportunities   Rising number of products by key players in the market
  Key Market Drivers

  • Increasing research studies being conducted for the treatment of hyperhidrosis
  • Extensive use of botulinum toxin injections


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    hyperhidrosis treatment market is projected grow at approximately 6.07% CAGR during the assessment period (2019-2025).

    The valuation of the global hyperhidrosis treatment market is estimated to increase to USD 1,925.9 MN by the end of 2025.

    By type, the primary hyperhidrosis segment and by treatment, the topical treatment segment segment holds the majority shares in the global hyperhidrosis treatment market.

    North America holds the largest share in the global hyperhidrosis treatment market, followed by Europe and the Asia Pacific, respectively.

    Brickell Biotech Inc. (US), Allergan PLC (Ireland), Cynosure (US), Dermira Inc. (US), Dermadry Laboratories inc. (Canada), GlaxoSmithKline PLC (UK), Sesderma (Spain), Miramar Labs, Inc. (US), and Ulthera Inc. (US), are some of the major players operating in the global hyperhidrosis treatment market.